Medical News, Journals & Upcoming Events
Most Read Psychiatry Articles on JAMA Network
- Adolescent Psychedelic Use and Psychotic or Manic Symptoms March 13, 2024This cross-sectional study evaluates the association between adolescent psychedelic use and self-reported psychotic or manic symptoms.
- Virtual Reality and Transcranial Direct Current Stimulation for Posttraumatic Stress Disorder March 6, 2024This randomized clinical trial assesses whether active transcranial direct current stimulation plus virtual reality is effective in treating warzone-related PTSD compared with to sham stimulation plus virtual reality.
- Adverse Childhood Experiences and Adult Mental Health Outcomes March 6, 2024This cohort study investigates the association of adverse childhood experiences with adult psychiatric disorders after adjusting for familial confounding.
- Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode March 1, 2024This randomized clinical trial investigates whether magnetic seizure therapy is as efficacious as ultrabrief pulse right unilateral electroconvulsive therapy in treating patients with major depressive episode.
- Psychotherapies for Generalized Anxiety Disorder in Adults March 1, 2024This systematic review and network meta-analysis of randomized clinical trials assesses the associations of various psychotherapies with short- and long-term effectiveness and acceptability for treatment of generalized anxiety disorder among adults.
JAMA Oncology Current Issue
- Atezolizumab in Combination With Carboplatin In Metastatic TNBC February 1, 2024This randomized clinical trial examines the efficacy of adding atezolizumab to treatment with carboplatin in patients with metastatic triple-negative breast cancer (TNBC), and the clinical or molecular correlates associated with disease response.
- Searching Beyond Programmed Cell Death Ligand 1 in Metastatic Breast Cancer February 1, 2024Despite great advances in breast cancer outcomes during the last decade, the benefit of immune checkpoint inhibitors (ICIs) remains limited to a select population of patients with triple-negative breast cancer (TNBC). Monotherapy ICIs have a limited role in breast cancer, with only tissue-agnostic indications, but combination ICI with chemotherapy is more successful with indications in […]
- Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Cervical Cancer February 1, 2024This randomized clinical trial evaluates the efficacy and safety of adding pembrolizumab to platinum-based chemotherapy with or without bevacizumab in women with cervical carcinoma that was not amenable to curative treatment.
- Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer February 1, 2024This open-label phase 2 randomized clinical trial evaluates the clinical effects and biomarker findings of treatment with neoadjuvant pembrolizumab and carboplatin plus docetaxel in patients with triple-negative breast cancer.
Upcoming Events
To receive information about upcoming events and the latest CE Activities, join our network.